New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future

• Published in: Italian journal of pediatrics Vol. 37; no. 1; p. 46
• Main Authors: Biagi, Ettore, Marin, Virna, Attianese, Greta Maria Paola Giordano, Pizzitola, Irene, Tettamanti, Sarah, Cribioli, Elisabetta, Biondi, Andrea
• Format: Journal Article
• Language: English
• Published: England BioMed Central 22-09-2011; BioMed Central Ltd; BMC
• Subjects: cell therapy; chimeric artificial receptors; Deoxyribonucleic acid; DNA; Gene therapy; Humans; Immunotherapy, Adoptive - methods; Immunotherapy, Adoptive - trends; Leukaemia immunotherapy; Leukemia - therapy; Leukemia, Lymphoid - therapy; Leukemia, Myeloid - therapy; Lymphocytes; Medical research; Peptide Fragments - immunology; Peptides; Receptors, Antigen, T-Cell - genetics; Receptors, Antigen, T-Cell - immunology; Recombinant Fusion Proteins - genetics; Recombinant Fusion Proteins - immunology; Review; Signal Transduction; Target recognition; Tumors
• ISSN: 1824-7288; 1720-8424; 1824-7288
• DOI: 10.1186/1824-7288-37-46

Leukaemia immunotherapy represents a fascinating and promising field of translational research, particularly as an integrative approach of bone marrow transplantation. Adoptive immunotherapy by the use of donor-derived expanded leukaemia-specific T cells has showed some kind of clinical response, but the major advance is nowadays represented by gene manipulation of donor immune cells, so that they acquire strict specificity towards the tumour target and potent lytic activity, followed by significant proliferation, increased survival and possibly anti-tumour memory state. This is achieved by gene insertion of Chimeric T-cell Antigen Receptors (CARs), which are artificial molecules containing antibody-derived fragments (to bind the specific target), joined with potent signalling T-Cell Receptor (TCR)-derived domains that activate the manipulated cells. This review will discuss the main application of this approach particularly focusing on the paediatric setting, raising advantages and disadvantages and discussing relevant perspectives of use in the nearest future.